Were there any clinically significant clinical chemistry abnormalities?
Yes
No
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
lf clinically significant, record primary reason for the clinically significant abnormality in by using the following key:
D - Due to disease under study (1)
C - Due to other concurrent disease (2)
T - Reasonable possibility due to investigational product (3)
M - Reasonable possibility due to other concomitant medication (4)
X - Other (5)
